121 related articles for article (PubMed ID: 31889319)
21. HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform.
Gholami M; Rouzbahani N; Samiee S; Tayeri K; Ghorban K; Dehkharghani AD; Gholami AA; Moshiri F; Sattari A; Dadmanesh M; Mohraz M
Microb Pathog; 2020 Sep; 146():104221. PubMed ID: 32360523
[TBL] [Abstract][Full Text] [Related]
22. Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs.
Kirichenko A; Lapovok I; Baryshev P; van de Vijver DAMC; van Kampen JJA; Boucher CAB; Paraskevis D; Kireev D
Viruses; 2020 Jul; 12(8):. PubMed ID: 32752001
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure.
van Hal SJ; Herring B; Deris Z; Wang B; Saksena NK; Dwyer DE
Retrovirology; 2009 Feb; 6():12. PubMed ID: 19203393
[TBL] [Abstract][Full Text] [Related]
24. Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients--impact of HIV subtypes and prior raltegravir experience.
Garrido C; Soriano V; Geretti AM; Zahonero N; Garcia S; Booth C; Gutierrez F; Viciana I; de Mendoza C
Antiviral Res; 2011 Jun; 90(3):164-7. PubMed ID: 21439330
[TBL] [Abstract][Full Text] [Related]
25. Circulating HIV-1 Integrase Genotypes in Tanzania: Implication on the Introduction of Integrase Inhibitors-Based Antiretroviral Therapy Regimen.
Masoud S; Kamori D; Barabona G; Mahiti M; Sunguya B; Lyamuya E; Ueno T
AIDS Res Hum Retroviruses; 2020 Jun; 36(6):539-543. PubMed ID: 32126792
[TBL] [Abstract][Full Text] [Related]
26. Molecular Genetics and the Incidence of Transmitted Drug Resistance Among Pre-Treatment HIV-1 Infected Patients in the Eastern Cape, South Africa.
Digban TO; Iweriebor BC; Obi LC; Nwodo U; Okoh AI
Curr HIV Res; 2019; 17(5):335-342. PubMed ID: 31584370
[TBL] [Abstract][Full Text] [Related]
27. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
[TBL] [Abstract][Full Text] [Related]
28. Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study.
Celotti A; Gargiulo F; Quiros-Roldan E; Properzi M; De Francesco MA; Coletto D; Caccuri F; Izzo I; Caruso A; Castelli F; Focà E
HIV Res Clin Pract; 2020 Feb; 21(1):24-33. PubMed ID: 32141388
[No Abstract] [Full Text] [Related]
29. Characterization of integrase region polymorphisms in HIV type 1 CRF06_cpx viruses in treatment-naive patients in Estonia.
Avi R; Huik K; Sadam M; Karki T; Krispin T; Ainsalu K; Paap P; Schmidt J; Nikitina N; Lutsar I
AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1109-13. PubMed ID: 20849300
[TBL] [Abstract][Full Text] [Related]
30. Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection.
Garrido C; Geretti AM; Zahonero N; Booth C; Strang A; Soriano V; De Mendoza C
J Antimicrob Chemother; 2010 Feb; 65(2):320-6. PubMed ID: 20007331
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children.
Fofana DB; Diarra H; Guindo I; Savadogo MK; d'Almeida M; Diallo FI; Baldé A; Soulié C; Kone A; Marcelin AG; Maiga AI; Lambert-Niclot S; Maiga M; McFall S; Hawkins CA; Murphy RL; Sylla M; Katlama C; Holl JL; Calvez V; Morand-Joubert L
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851760
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients.
Malet I; Wirden M; Fourati S; Armenia D; Masquelier B; Fabeni L; Sayon S; Katlama C; Perno CF; Calvez V; Marcelin AG; Ceccherini-Silberstein F
J Antimicrob Chemother; 2011 Jul; 66(7):1481-3. PubMed ID: 21474479
[TBL] [Abstract][Full Text] [Related]
33. Integrase Strand Transfer Inhibitor Resistance in Integrase Strand Transfer Inhibitor-Naive Persons.
Bailey AJ; Rhee SY; Shafer RW
AIDS Res Hum Retroviruses; 2021 Oct; 37(10):736-743. PubMed ID: 33683148
[TBL] [Abstract][Full Text] [Related]
34. Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance.
Tschochner M; Chopra A; Maiden TM; Ahmad IF; James I; Furrer H; Günthard HF; Mallal S; Rauch A; John M
Antivir Ther; 2009; 14(7):953-64. PubMed ID: 19918099
[TBL] [Abstract][Full Text] [Related]
35. Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.
Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Rinke de Wit TF; Paredes R
J Antimicrob Chemother; 2018 May; 73(5):1167-1172. PubMed ID: 29462322
[TBL] [Abstract][Full Text] [Related]
36. Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations.
Charpentier C; Descamps D
Viruses; 2018 Jan; 10(1):. PubMed ID: 29346270
[TBL] [Abstract][Full Text] [Related]
37. Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naïve individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group study.
Nouhin J; Donchai T; Hoang KT; Ken S; Kamkorn J; Tran T; Ayouba A; Peeters M; Chaix ML; Lien TX; Nerrienet E; Ngo-Giang-Huong N
Infect Genet Evol; 2011 Jan; 11(1):38-43. PubMed ID: 21094281
[TBL] [Abstract][Full Text] [Related]
38. Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors.
Rhee SY; Liu TF; Kiuchi M; Zioni R; Gifford RJ; Holmes SP; Shafer RW
Retrovirology; 2008 Aug; 5():74. PubMed ID: 18687142
[TBL] [Abstract][Full Text] [Related]
39. Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Treatment-naïve Patients in Korea: a Prospective, Observational Study.
Kim Y; Chin BS; Kim G; Shin HS
J Korean Med Sci; 2018 Jun; 33(25):e173. PubMed ID: 29915524
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 Integrase Resistance among Highly Antiretroviral Experienced Patients from Morocco.
Alaoui N; El Alaoui MA; El Annaz H; Farissi FZ; Alaoui AS; El Fahime E; Mrani S
Intervirology; 2019; 62(2):65-71. PubMed ID: 31307042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
